Bezafibrate for an inborn mitochondrial beta-oxidation defect.
Bonnefont
Jean-Paul
JP
Bastin
Jean
J
Behin
Anthony
A
Djouadi
Fatima
F
D000328:Adult; D001629:Bezafibrate / Q000627:therapeutic use*; D002334:Carnitine O-Palmitoyltransferase / Q000172:deficiency* / Q000378:metabolism; D005808:Genes, Recessive; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy* / Q000378:metabolism; D028361:Mitochondrial Diseases / Q000188:drug therapy* / Q000378:metabolism; D010084:Oxidation-Reduction; D010172:Palmitoylcarnitine / Q000378:metabolism; D010865:Pilot Projects; D011788:Quality of Life; D012333:RNA, Messenger / Q000378:metabolism; D012206:Rhabdomyolysis / Q000517:prevention & control; D018709:Statistics, Nonparametric
D000960:Hypolipidemic Agents; D012333:RNA, Messenger; D010172:Palmitoylcarnitine; D002334:Carnitine O-Palmitoyltransferase; D001629:Bezafibrate